192 related articles for article (PubMed ID: 8112235)
1. Disposition of carbamazepine and phenytoin in pregnancy.
Tomson T; Lindbom U; Ekqvist B; Sundqvist A
Epilepsia; 1994; 35(1):131-5. PubMed ID: 8112235
[TBL] [Abstract][Full Text] [Related]
2. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin.
Tomson T; Lindbom U; Ekqvist B; Sundqvist A
Epilepsia; 1994; 35(1):122-30. PubMed ID: 8112234
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
Christensen J; Sabers A; Sidenius P
Neurology; 2006 Oct; 67(8):1497-9. PubMed ID: 17060586
[TBL] [Abstract][Full Text] [Related]
4. Plasma antiepileptic drug concentrations during pregnancy.
Lander CM; Eadie MJ
Epilepsia; 1991; 32(2):257-66. PubMed ID: 2004630
[TBL] [Abstract][Full Text] [Related]
5. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
Duncan JS; Patsalos PN; Shorvon SD
Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
[TBL] [Abstract][Full Text] [Related]
6. The 10,11-epoxide-10,11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, comedication, and relation to outcome of pregnancy.
Omtzigt JG; Los FJ; Meijer JW; Lindhout D
Ther Drug Monit; 1993 Feb; 15(1):1-10. PubMed ID: 8451773
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
[TBL] [Abstract][Full Text] [Related]
8. Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.
Qu L; Fan Y; Wang W; Ma K; Yin Z
Talanta; 2016 Sep; 158():77-88. PubMed ID: 27343581
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
Zielinski JJ; Haidukewych D; Leheta BJ
Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine clearance and seizure stability during pregnancy.
Johnson EL; Stowe ZN; Ritchie JC; Newport DJ; Newman ML; Knight B; Pennell PB
Epilepsy Behav; 2014 Apr; 33():49-53. PubMed ID: 24632353
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy.
Ojemann LM; Shastri RA; Wilensky AJ; Friel PN; Levy RH; McLean JR; Buchanan RA
Ther Drug Monit; 1986; 8(3):293-6. PubMed ID: 3750373
[TBL] [Abstract][Full Text] [Related]
13. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures.
Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R
Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
15. Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy.
May T; Jürgens U; Rambeck B; Schnabel R
Epilepsy Res; 1999 Jan; 33(1):57-65. PubMed ID: 10022366
[TBL] [Abstract][Full Text] [Related]
16. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR
Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
[TBL] [Abstract][Full Text] [Related]
17. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
Wlaź P; Roliński Z; Czuczwar SJ
Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
19. Effect of single- and multiple-dose carbamazepine on the pharmacokinetics of diphenylhydantoin.
Lai ML; Lin TS; Huang JD
Eur J Clin Pharmacol; 1992; 43(2):201-3. PubMed ID: 1425879
[TBL] [Abstract][Full Text] [Related]
20. First and Second Trimester Biochemical Markers in Maternal Epilepsy: A Case-Control Study.
Oksuzoglu A; Engin Ustun Y; Aktulay A; Yoruk O; Seckin B; Danisman N
Fetal Pediatr Pathol; 2018 Oct; 37(5):319-325. PubMed ID: 30247941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
